Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Price analysis NEOLA®

Reference number
Coordinator GPX Medical AB
Funding from Vinnova SEK 183 146
Project duration May 2022 - November 2022
Status Completed
Venture Medtech4Health: Competence Enhancement in SME
Call Medtech4Health: Skills enhancement in small businesses 2022

Important results from the project

** Denna text är maskinöversatt ** The purpose of the project was to carry out a price analysis to get an understanding of how potential price levels for NEOLA® affected the market´s willingness to purchase the product. The price analysis has given the Company exactly the understanding it sought. Today, the Company knows what price levels the American market can tolerate and the expected impact NEOLA® can have on the American market.

Expected long term effects

The project gives GPX Medical a much stronger foundation to be able to achieve international success in the United States by laying the foundation for commercialization in the American market. In addition, the company´s competitiveness is strengthened as the right knowledge of the willingness to pay for different price models means that the company can set the right price level for NEOLA®.

Approach and implementation

The project is closely linked to our commercialization strategy for the US market and the work included: - Cost analysis of NEOLA® - Development of various potential price models and price levels for evaluation - Implementation and analysis of a potential market research buyer - Development of final initial sales price and payment model for NEOLA® - Implementation of project insights in the market strategy for the US market

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 20 January 2023

Reference number 2022-00895